Accès à distance ? S'identifier sur le proxy UCLouvain
Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 1999 |
| Language | Anglais |
| Journal information | "Blood" - Vol. 94, no. 10, p. 382B-382B (1999) |
| Peer reviewed | yes |
| issn | 0006-4971 |
| e-issn | 1528-0020 |
| Publisher | Amer Soc Hematology (Washington) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL |
| Links |
| Bibliographic reference | deWitte, TM ; Ferrant, Augustin ; Suciu, Stefan ; Anak, O ; Hagemeijer, Anne ; et. al. Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project..In: Blood, Vol. 94, no. 10, p. 382B-382B (1999) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/62192 |